Holen Sie sich die Stockscreener-App
2.23
0.45%
0.010
Schlusskurs vom Vortag:
$2.22
Offen:
$2.44
24-Stunden-Volumen:
47,011
Relative Volume:
0.61
Marktkapitalisierung:
$9.94M
Einnahmen:
$1.54M
Nettoeinkommen (Verlust:
$-8.87M
KGV:
-0.0628
EPS:
-35.4915
Netto-Cashflow:
$-2.74M
1W Leistung:
-1.33%
1M Leistung:
+42.04%
6M Leistung:
-99.03%
1J Leistung:
-99.21%
1-Tages-Spanne:
$2.1801
$2.44
1-Wochen-Bereich:
$2.16
$2.7699
52-Wochen-Spanne:
$1.2501
$1,046.98
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
2.23 | 9.94M | 1.54M | -8.87M | -2.74M | -35.49 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
China Sxt Pharmaceuticals Inc Aktie (SXTC) Neueste Nachrichten
China SXT Pharmaceuticals Inc (SXTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
China SXT Pharmaceuticals Inc - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Institutional Confidence - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
China SXT Pharmaceuticals Company Profile & Introduction - Moomoo
China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why - Sahm
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
China SXT Pharmaceuticals shares surge over 25% after hours: Here's why - MSN
China SXT Pharmaceuticals Launches $100 Million ATM Equity Program with Univest Securities - The Globe and Mail
China SXT Pharmaceuticals (SXTC) launches $100M ATM offering with Univest - Stock Titan
China SXT (NASDAQ: SXTC) sets up $100M at-the-market share offering - Stock Titan
China SXT Pharmaceuticals (SXTC) Surges 7%: Potential Breakout Above ResistanceTriple MA Cross - newsline.com
China SXT Pharmaceuticals (SXTC) Slips 3% as Stock Tests Key Support LevelsLow Volume Node - newsline.com
SXTC Faces Selling Pressure: Key Levels to Watch After 7.3% DeclineStraddle Setup - newsline.com
China SXT Pharmaceuticals (SXTC) Sees Uptick Amid Support HoldingVolume Rate Change - Newser
SXTC Should I Buy - Intellectia AI
TradingKey - TradingKey
SXTC Technical Analysis | Trend, Signals & Chart Patterns | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
China SXT Pharmaceuticals Raises $3.5 Million in Offshore Private Placement - The Globe and Mail
China SXT Pharmaceuticals Inc (SXTC) - MSN
China SXT (NASDAQ: SXTC) prices $3.5M Reg S share and warrant deal - Stock Titan
MSN Money - MSN
SXTC Stock Price, Quote & Chart | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
What guidance trend China SXT (SXTC)? (Bearish Momentum) 2026-04-29Volume Breakout - newser.com
China SXT Pharmaceuticals (SXTC) Co-CEO reports indirect Class B stake - Stock Titan
China SXT Pharmaceuticals (SXTC) CFO listed as insider in Form 3 - Stock Titan
China SXT Pharmaceuticals (SXTC) director Chee Yong Lip files Form 3 - Stock Titan
Director Ji Xiaodong files Form 3 for China SXT (SXTC) - Stock Titan
Director Liu Tong Tony files Form 3 at China SXT (SXTC) - Stock Titan
Co-CEO Simon Lim listed in China SXT (SXTC) Form 3 with no trades - Stock Titan
[Form 3] China SXT Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan
China SXT (SXTC) Sector Leadership | Q1 2025: Earnings ReportCommunity Sell Signals - Xã Thanh Hà
China SXT (SXTC) Stock: Why Industry Position (Bullish Sentiment) 2026-04-22Cash Flow - Cổng thông tin điện tử tỉnh Lào Cai
China SXT (SXTC) Stock Days to Cover (Smart Money Exits) 2026-04-15Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Tây Ninh
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
China SXT Pharmaceuticals Raises $760,000 in Registered Share Offering - The Globe and Mail
China SXT Pharmaceuticals announces $760,000 share offering on Monday By Investing.com - Investing.com India
China SXT Pharmaceuticals announces $760,000 share offering on Monday - Investing.com
SXTC (NASDAQ: SXTC) sells 2M Class A shares at $0.38 for $760K - Stock Titan
China SXT (SXTC) raises about $760K in 2M-share stock offering - Stock Titan
Breakout Move: Is China SXT Pharmaceuticals Inc undervalued by DCF analysisEarnings Growth Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Is China SXT (SXTC) Stock Growing Now | Price at $1.90, Up 0.53%Bollinger Squeeze - The Legal Advocate
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
Aug Action: What is the target price for China SXT Pharmaceuticals Inc stockTrend Reversal & Target Return Focused Picks - baoquankhu1.vn
Finanzdaten der China Sxt Pharmaceuticals Inc-Aktie (SXTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.23%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):